Preliminary results of a multicenter randomized phase II trial of two different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC)

被引：0
|
作者：
Bernardini, I
Rinaldi, M
Crinò, L
Nardi, M
De Marinis, F
Tonato, M
Sguotti, C
Vallauri, L
Scagliotti, G
Novello, S
机构：
[1] Med Oncol, Livorno, Italy
[2] Regina Elena Hosp, Rome, Italy
[3] Bellaria Hosp, Bologna, Italy
[4] Osped Riuniti Bergamo, Reggio Di Calabria, Italy
[5] Forlanini Hosp, Rome, Italy
[6] Med Oncol, Perugia, Italy
[7] Univ Turin, I-10124 Turin, Italy
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S239 / S239
页数：1
相关论文
共 50 条
  • [1] Preliminary results of a multicenter randomized phase II trial of two different combinations of docetaxel (D) and gemcitabine (G) and of cisplatin/gemcitabine (CG) followed by docetaxel as first line therapy for locally advanced or metastatic non small cell lung cancer (NSCLC).
    Rinaldi, M
    Novello, S
    Bernardini, I
    Crinò, L
    Nardi, M
    de Marinis, F
    Tonato, M
    Sguotti, C
    Marini, L
    Scagliotti, GV
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 651S - 651S
  • [2] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial
    D. Binder
    H. Schweisfurth
    C. Grah
    C. Schäper
    B. Temmesfeld-Wollbrück
    G. Siebert
    N. Suttorp
    T. Beinert
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 143 - 150
  • [3] Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: results of a multicentre randomized phase II trial
    Binder, D.
    Schweisfurth, H.
    Grah, C.
    Schaeper, C.
    Temmesfeld-Wollbrueck, B.
    Siebert, G.
    Suttorp, N.
    Beinert, T.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 143 - 150
  • [4] Randomised multicenter phase II study of two schedules of docetaxel and gemcitabine or cisplatin/gemcitabine followed by docetaxel as first line treatment for advanced non-small cell lung cancer
    Novello, Silvia
    Falcone, Alfredo
    Crino, Lucio
    Rinaldi, Massimo
    Nardi, Mario
    De Marinis, Filippo
    Tonato, Maurizio
    Tibaldi, Carmelo
    Tinazzi, Angelo
    Russo, Francesca
    Grassivaro, Nicoletta
    Scagliotti, Giorgio Vittorio
    LUNG CANCER, 2009, 66 (03) : 327 - 332
  • [5] Docetaxel/gemcitabine vs. cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: Results of a randomised phase II trial
    Binder, D
    Schweisfurth, H
    Grah, C
    Schäper, C
    Temmesfeld-Wollbrück, B
    Siebert, G
    Suttorp, N
    Beinert, T
    LUNG CANCER, 2005, 49 : S237 - S237
  • [6] Docetaxel-gemcitabine versus cisplatin-gemcitabine plus sequential docetaxel in the first-line treatment of metastatic non-small cell lung cancer (NSCLC): interim results of a randomized Phase II trial
    Binder, Daniel
    Beinert, Thomas
    Schweisfurth, Hans
    Grah, Christian
    Temmestfeld-Wollbrueck, Bettina
    Schaeper, Christoph
    Mueller-Hagen, Gerit
    Schuermann, Dirk
    Suttorp, Norbert
    ANNALS OF ONCOLOGY, 2004, 15 : 178 - 178
  • [7] Randomized phase II trial of two sequential schedules of docetaxel (D) and cisplatin (C) followed by gemcitabine (G) in patients with advanced non-small cell lung cancer
    Galligioni, E.
    Gebbia, V.
    Carteni, G.
    Gamucci, T.
    Grossi, F.
    Ferrau, F.
    Nardi, M.
    Pollera, C.
    Rossi, S.
    De Marinis, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] Docetaxel plus cisplatin versus docetaxel plus gemcitabine chemotherapy in advanced non-small cell lung cancer: A preliminary analysis of a multicenter randomized phase II trial
    Georgoulias, V
    Papadakis, E
    Alexopoulos, A
    Stavrinidis, E
    Bania, E
    Rapti, A
    Grigoratou, T
    Kouroussis, C
    Kakolyris, S
    Samonis, G
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S249 - S249
  • [9] Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial
    Georgoulias, V
    Samonis, G
    Papadakis, E
    Alexopoulos, A
    Tsiafaki, X
    Rapti, A
    Veslemes, M
    Grigoratou, T
    Palamidas, P
    Kourossis, C
    Mavroudis, D
    Kakolyris, S
    Giannakakis, T
    Vlachonikolis, J
    LUNG CANCER, 2001, 34 : S47 - S51
  • [10] Results of a phase II multicenter trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer
    Neubauer, MA
    Garfield, DH
    Kuerfler, PR
    Raju, RN
    Lindquist, DL
    Soo, EW
    Khan, M
    Boehm, KA
    Asmar, L
    LUNG CANCER, 2005, 47 (01) : 121 - 127
12345